WallStreetZenWallStreetZen

NASDAQ: ALPN
Alpine Immune Sciences Inc Stock Ownership - Who owns Alpine Immune Sciences?

Insider buying vs selling

Have Alpine Immune Sciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
James Paul RickeySenior Vice President Chief Financial Officer and Corporate Secretary2024-01-2644,000$11.31
$497.64kBuy
James Paul RickeySenior Vice President Chief Financial Officer and Corporate Secretary2024-01-2673,764$22.31
$1.65MSell
James Paul RickeySenior Vice President Chief Financial Officer and Corporate Secretary2024-01-2673,764$6.51
$480.20kBuy
James Paul RickeySenior Vice President Chief Financial Officer and Corporate Secretary2024-01-2644,000$25.00
$1.10MSell
James Paul RickeySenior Vice President Chief Financial Officer and Corporate Secretary2024-01-25236$22.00
$5.19kSell
James Paul RickeySenior Vice President Chief Financial Officer and Corporate Secretary2024-01-25236$6.51
$1.54kBuy
Xiangmin CuiDirector2024-01-181,234,636$12.74
$15.73MBuy
Decheng Capital China Life Sciences Usd Fund Iii LP10% Owner2024-01-181,234,636$12.74
$15.73MBuy
Peter A. ThompsonDirector2024-01-11145,251$12.74
$1.85MBuy
Orbimed Advisors LLCDirector2024-01-11145,251$12.74
$1.85MBuy

1 of 7

ALPN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALPN insiders and whales buy or sell their stock.

ALPN Shareholders

What type of owners hold Alpine Immune Sciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Decheng Capital China Life Sciences Usd Fund Iii LP13.67%7,942,924$262.99MInsider
Decheng Capital LLC12.19%7,083,288$234.53MInstitution
Jay Venkatesan11.83%6,871,153$227.50MInsider
Mitchell Gold9.29%5,398,672$178.75MInsider
Ra Capital Management LP8.45%4,909,763$162.56MInstitution
James N. Topper6.59%3,828,377$126.76MInsider
Lynx1 Capital Management LP6.56%3,813,926$126.28MInstitution
James E. Flynn6.42%3,732,412$123.58MInsider
Great Point Partners LLC6.37%3,703,433$122.62MInstitution
Paradigm Biocapital Advisors LP5.47%3,176,743$105.18MInstitution

1 of 3

ALPN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALPN59.43%40.57%Net BuyingNet Selling
ZLAB4.16%1.97%Net BuyingNet Selling
TGTX53.77%46.23%Net SellingNet Selling
ARDX38.01%61.99%Net SellingNet Selling
KROS70.92%29.08%Net Buying

Alpine Immune Sciences Stock Ownership FAQ

Who owns Alpine Immune Sciences?

Alpine Immune Sciences (NASDAQ: ALPN) is owned by 101.41% institutional shareholders, 69.23% Alpine Immune Sciences insiders, and 0.00% retail investors. Decheng Capital China Life Sciences Usd Fund Iii LP is the largest individual Alpine Immune Sciences shareholder, owning 7.94M shares representing 13.67% of the company. Decheng Capital China Life Sciences Usd Fund Iii LP's Alpine Immune Sciences shares are currently valued at $269.42M.

If you're new to stock investing, here's how to buy Alpine Immune Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.